Cargando…

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer

Although many anticancer drugs have been developed for triple-negative breast cancer (TNBC) treatment, there are no obvious therapies. Moreover, the combination of epidermal growth factor receptor- (EGFR-) targeted therapeutics and classical chemotherapeutic drugs has been assessed in clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yu-Jeong, Lee, Kangwook, Yoon, Ji-Hye, Cho, Sung-Gook, Kim, Yun-Gyeong, Jeong, Miso, Hwang, Hyun-Ha, Lee, Seo Yeon, Jung, Se-Eun, Ko, Seong-Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098291/ https://www.ncbi.nlm.nih.gov/pubmed/35572726 http://dx.doi.org/10.1155/2022/3647900

Ejemplares similares

Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer
por: Jeong, Mi-So, et al.
Publicado: (2021)

Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL/6 Mice
por: Lee, Kangwook, et al.
Publicado: (2021)

Metabolomic Analysis of Exosomes Derived from Lung Cancer Cell Line H460 Treated with SH003 and Docetaxel
por: Choi, Yu-Jeong, et al.
Publicado: (2022)

State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent
por: Lee, Kangwook, et al.
Publicado: (2022)

SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes
por: Choi, Youn Kyung, et al.
Publicado: (2016)

SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway
por: Choi, Yu-Jeong, et al.
Publicado: (2016)

Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2020)

Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells
por: Lee, Sang-Han, et al.
Publicado: (2021)

Analgesic Effect of SH003 and Trichosanthes kirilowii Maximowicz in Paclitaxel-Induced Neuropathic Pain in Mice
por: Lee, Ji Hwan, et al.
Publicado: (2022)

A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003 in Patients With Solid Cancer
por: Cheon, Chunhoo, et al.
Publicado: (2020)

Herbal Extract SH003 Suppresses Tumor Growth and Metastasis of MDA-MB-231 Breast Cancer Cells by Inhibiting STAT3-IL-6 Signaling
por: Choi, Youn Kyung, et al.
Publicado: (2014)

SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells
por: Seo, Hye-Sook, et al.
Publicado: (2017)

SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells
por: Kim, Tae Woo, et al.
Publicado: (2020)

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

The Mixture of Natural Products SH003 Exerts Anti-Melanoma Effects through the Modulation of PD-L1 in B16F10 Cells
por: Han, Na-Ra, et al.
Publicado: (2023)

Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs
por: Choi, Jinhyang, et al.
Publicado: (2015)

Bamboo Salt and Triple Therapy Synergistically Inhibit Helicobacter pylori-Induced Gastritis In Vivo: A Preliminary Study
por: Lee, Tae Ho, et al.
Publicado: (2022)

The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells
por: Tam, Stanton, et al.
Publicado: (2022)

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

Redox imbalance induced by docetaxel in the neuroblastoma SH-SY5Y cells: a study of docetaxel-induced neuronal damage
por: Micheli, Lucia, et al.
Publicado: (2021)

Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2018)

A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment
por: Lee, Ho-Sung, et al.
Publicado: (2021)

Top Physics at ATLAS 003
por: Stavropoulos, G D
Publicado: (2004)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology
por: Lee, Ho-Sung, et al.
Publicado: (2022)

Synergistic enhancement of cell death by triple combination therapy of docetaxel, ultrasound and microbubbles, and radiotherapy on PC3 a prostate cancer cell line
por: Almasri, Firas, et al.
Publicado: (2022)

Evaluation of the Physicochemical Properties, Pharmacokinetics, and In Vitro Anticancer Effects of Docetaxel and Osthol Encapsulated in Methoxy Poly(ethylene glycol)-b-Poly(caprolactone) Polymeric Micelles
por: Jo, Min Jeong, et al.
Publicado: (2020)

Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations
por: Duggirala, Krishna Babu, et al.
Publicado: (2022)

P003 Synthetic antifungal peptide mimic kills Candida albicans by targeting protein glycosylation and synergistically prevents infection
por: Schaefer, Sebastian, et al.
Publicado: (2022)

Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel
por: Feng, Li-Xia, et al.
Publicado: (2014)

Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
por: Lim, Hyun-Kyung, et al.
Publicado: (2016)

Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells
por: Lin, Changyi, et al.
Publicado: (2020)

OR11-003 - The NLRP3 inflammasome is regulated by CaSR
por: Chae, JJ, et al.
Publicado: (2013)

Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients
por: Kim, Yoonjung, et al.
Publicado: (2013)

Synergistic effects of natural products in combination with anticancer agents in prostate cancer: A scoping review
por: Cheon, Chunhoo, et al.
Publicado: (2022)

Anticancer bioactive peptide combined with docetaxel and its mechanism in the treatment of breast cancer
por: Li, Xian, et al.
Publicado: (2020)

Biodegradable Magnetic Molecularly Imprinted Anticancer Drug Carrier for the Targeted Delivery of Docetaxel
por: Ali, Zeeshan, et al.
Publicado: (2022)

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_oq3ck3bie7amsaib2kr65o1flb